洞察市场格局
解锁药品研发情报

客服电话

400-9696-311

医药数据查询

【ChiCTR-IPR-14005492】The effectiveness of a Diabetes Empowerment Self-Management Intervention program on the glycemic control and self-management behaviors for patients with poor glycemic control

查看原文

立即下载

基本信息

登记号

ChiCTR-IPR-14005492

试验状态

正在进行

药物名称

药物类型

规范名称

首次公示信息日的期

2014-11-14

临床申请受理号

靶点

适应症

Diabetes

试验通俗题目

The effectiveness of a Diabetes Empowerment Self-Management Intervention program on the glycemic control and self-management behaviors for patients with poor glycemic control

试验专业题目

The effectiveness of a Diabetes Empowerment Self-Management Intervention program on the glycemic control and self-management behaviors for patients with poor glycemic control

申办单位信息

申请人联系人

请登录查看

申请人名称

请登录查看

联系人邮箱

请登录查看

联系人邮编

联系人通讯地址

请登录查看

临床试验信息

试验目的

Aim of the study: The purpose of the study is to examine the effectiveness of a culturally-tailored Diabetes Empowerment Self-Management intervention (DESMI) program on glycemic control and self-management behaviors among the Chinese diabetic patients with poor glycemic control.

试验分类

请登录查看

试验类型

随机平行对照

试验分期

Ⅳ期

随机化

block randomization (generated by computer program)

盲法

试验项目经费来源

Self- financing

试验范围

目标入组人数

242

实际入组人数

第一例入组时间

2014-05-26

试验终止时间

1990-01-01

是否属于一致性

入选标准

Subjects will be recruited from two comprehensive 3-A hospitals in Xi'an City. Inclusion criteria are: (1) being diagnosed with type 2 diabetes,(2) with HbA1c more than 7.5%,(3) willing to participate in this study, (4) available for telephone follow-up.；

排除标准

Exclusion criteria are: (1) secondary diabetes or gestational diabetes; (2) evolving cancer with current/ planned treatment; (3) involving in other interventional therapy; (4) planning to move out from the Xi'an city within one year; (5) diagnosed with psychiatric disease currently receiving treatment; (6) serious cognitive problems with Abbreviated Mental Test less than 7 that could affect the participation in the proposed intervention program; (7) serious medical or health condition likely to hinder the self-management of diabetes (e.g., end-stage renal disease on dialysis, blindness, heart failure).；

研究者信息

研究负责人姓名

请登录查看

试验机构

The Chinese University of Hong Kong

研究负责人电话

请登录查看

研究负责人邮箱

请登录查看

研究负责人邮编

联系人通讯地址

请登录查看